7 Lessons from DCTs: Moving Up the Slope of Enlightenment

This article summary is based on "eCOA and the DCT Slope of Enlightenment" by Bill Byrom, Anthony Everhart, and Dan DeBonis, originally published in International Clinical Trials, February 2023.

The life sciences industry is traditionally risk-averse when it comes to implementing new technologies, but COVID-19 and the need to continue trials throughout the pandemic accelerated adoption of technology that enabled decentralized clinical trials (DCT).

Now post-pandemic, where does the industry currently lie on the adoption trajectory? While some sponsors may have arrived at the “trough of disillusionment” due to variable results from the application of less mature solutions, this analysis suggests we're already progressing along the "slope of enlightenment" by building on established practices rather than reinventing trial methodologies.

Download the article to learn how implementing robust eCOA solutions enhanced with carefully selected decentralized methodologies can improve both scientific integrity and patient experience in your clinical trials.